 |
Trial Information
Summary: Research study of an experimental pain medication for patients with pain related to cancer.Patients must be taking an opioid narcotic pain medication for at least 2 weeks prior to entering the study and have pain expected to last at least 90 days. The study is 12 weeks long with 6 outpatient visits. Participants will receive a physical examination, lab work, and study medication. Patients will continue with their opioid medication. Eligible patients will have chronic pain related to cancer and meet inclusion and exclusion criteria. Patients must be taking opioid (narcotic medications for at least 2 weeks prior to entering the study and have pain expected to last 90 days. Patients will receive a physical examination, and have blood drawn for laboratory work.
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received. This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials. Trial listings updated: June 1, 2008 at 5:43:17 AM |
|
|
Patient Resources: [ Trial Listing
] [ Notification Services ] [ Drug
Directories ]
Copyright © 1995 - 2008, CenterWatch |
